Literature DB >> 15105904

P-31 magnetic resonance spectroscopy. A tool for diagnostic purposes and pathophysiological insights in muscle diseases.

J P Mattei1, D Bendahan, P Cozzone.   

Abstract

31P Magnetic Resonance Spectroscopy (MRS) is a potent tool allowing the investigation of muscle energetics in a noninvasive manner in humans. This review details the contribution of 31P MRS to the diagnosis of metabolic myopathies and provides some clues for the use of this technique in a clinical perspective. Finally, the contribution of 31P MRS to our understanding of the physiopathology of several other diseases is highlighted.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15105904     DOI： 10.4081/reumatismo.2004.9

Source DB:  PubMed          Journal:  Reumatismo        ISSN： 0048-7449


  5 in total

1.  31P MR spectroscopy and in vitro markers of oxidative capacity in type 2 diabetes patients.

Authors:  S F E Praet; H M M De Feyter; R A M Jonkers; K Nicolay; C van Pul; H Kuipers; L J C van Loon; J J Prompers
Journal:  MAGMA       Date:  2006-12-19       Impact factor: 2.310

2.  Impaired in vivo mitochondrial function but similar intramyocellular lipid content in patients with type 2 diabetes mellitus and BMI-matched control subjects.

Authors:  V B Schrauwen-Hinderling; M E Kooi; M K C Hesselink; J A L Jeneson; W H Backes; C J A van Echteld; J M A van Engelshoven; M Mensink; P Schrauwen
Journal:  Diabetologia       Date:  2006-11-09       Impact factor: 10.122

Review 3.  MR compatible ergometers for dynamic 31P MRS.

Authors:  Petr Sedivy; Monika Dezortova; Jan Rydlo; Miloslav Drobny; Martin Krssak; Ladislav Valkovic; Milan Hajek
Journal:  J Appl Biomed       Date:  2019-04-15       Impact factor: 1.797

4.  Restoration of muscle mitochondrial function and metabolic flexibility in type 2 diabetes by exercise training is paralleled by increased myocellular fat storage and improved insulin sensitivity.

Authors:  Ruth C R Meex; Vera B Schrauwen-Hinderling; Esther Moonen-Kornips; Gert Schaart; Marco Mensink; Esther Phielix; Tineke van de Weijer; Jean-Pierre Sels; Patrick Schrauwen; Matthijs K C Hesselink
Journal:  Diabetes       Date:  2009-12-22       Impact factor: 9.461

5.  L-Arginine Affects Aerobic Capacity and Muscle Metabolism in MELAS (Mitochondrial Encephalomyopathy, Lactic Acidosis and Stroke-Like Episodes) Syndrome.

Authors:  Lance H Rodan; Greg D Wells; Laura Banks; Sara Thompson; Jane E Schneiderman; Ingrid Tein
Journal:  PLoS One       Date:  2015-05-20       Impact factor: 3.240
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.